UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Rabeprazole in treatment of acid peptic diseases : Results of three placebo-controlled dose-response clinical trials in duodenal ulcer, gastric ulcer, and gastroesophageal reflux disease (GERD)

Digestive diseases and sciences, 1998-05, Vol.43 (5), p.993-1000

1998

Volltextzugriff (PDF)

Nizatidine versus placebo in gastroesophageal reflux disease : a 12-week, multicenter, randomized, double-blind study

The American journal of gastroenterology, 1991-12, Vol.86 (12), p.1735-1742

1991

Volltextzugriff (PDF)

Continuous Infusions of Nizatidine Are Safe and Effective in the Treatment of Intensive Care Unit Patients at Risk for Stress Gastritis

Scandinavian journal of gastroenterology, 1994, Vol.29 (S206), p.29-34

1994

Volltextzugriff (PDF)

Safety of Nizatidine in Clinical Trials Conducted in the USA and Europe

Scandinavian journal of gastroenterology, 1987, Vol.22 (S136), p.29-36

Cloud, M. L.

1987

Volltextzugriff (PDF)

Healing and recurrence of active duodenal ulcer with nizatidine

Clinical pharmacology and therapeutics, 1989-09, Vol.46 (3), p.310-316

1989

Volltextzugriff (PDF)

A Test of the Bicolored Fruit Display Hypothesis: Berry Removal with Artificial Fruit Flags

The journal of the Torrey Botanical Society, 2003-01, Vol.130 (1), p.30

2003

Volltextzugriff (PDF)

Nizatidine versus placebo in gastroesophageal reflux disease : a six-week, multicenter, randomized, double-blind comparison

Digestive diseases and sciences, 1992-06, Vol.37 (6), p.865-874

1992

Volltextzugriff (PDF)

Nizatidine as Maintenance Therapy of Duodenal Ulcer Disease in Remission

Scandinavian journal of gastroenterology, 1987, Vol.22 (S136), p.79-83

1987

Volltextzugriff (PDF)

Treatment of Duodenal Ulceration in the United States

Scandinavian journal of gastroenterology, 1987, Vol.22 (S136), p.47-55

1987

Volltextzugriff (PDF)

Healing and subsequent recurrence of duodenal ulcer in a clinical trial comparing nizatidine 300-mg and 100-mg evening doses and placebo in the treatment of active duodenal ulcer

Current therapeutic research, 1989-03, Vol.45 (3), p.359-367

1989

Volltextzugriff (PDF)

A specific LTD4/LTE4-receptor antagonist improves pulmonary function in patients with mild, chronic asthma

The American review of respiratory disease, 1989-11, Vol.140 (5), p.1336

1989

Volltextzugriff (PDF)

Comparison of nizatidine and cimetidine as once-nightly treatment of acute duodenal ulcer

The American journal of gastroenterology, 1989-07, Vol.84 (7), p.769-774

1989

Volltextzugriff (PDF)

A Brief Review of Preclinical and Clinical Studies with LY171883 and Some Comments on Newer Cysteinyl Leukotriene Receptor Antagonists

Annals of the New York Academy of Sciences, 1988, Vol.524 (1), p.356-368

1988

Volltextzugriff (PDF)

Nizatidine prevents peptic ulceration in high-risk patients taking nonsteroidal anti-inflammatory drugs

Archives of internal medicine (1960), 1993-11, Vol.153 (21), p.2449

1993

Volltextzugriff (PDF)

Rabeprazole in treatment of acid peptic diseases: results of three placebo-controlled dose-response clinical trials in duodenal ulcer, gastric ulcer, and gastroesophageal reflux disease (GERD). The Rabeprazole Study Group

Digestive diseases and sciences, 1998-05, Vol.43 (5), p.993-1000

1998

Volltextzugriff (PDF)

Rabeprazole in treatment of acid peptic diseases (results of three placebo-controlled dose-response clinical trials in duodenal ulcer, gastric ulcer, and gastroesophageal reflux disease (GERD))

Digestive diseases and sciences, 1998-05, Vol.43 (5), p.993

1998

Volltextzugriff (PDF)

Nizatidine versus placebo in gastroesophageal reflux disease. A six-week, multicenter, randomized, double-blind comparison. Nizatidine Gastroesophageal Reflux Disease Study Group

Digestive diseases and sciences, 1992-06, Vol.37 (6), p.865-874

1992

Volltextzugriff (PDF)

Continuous infusions of nizatidine are safe and effective in the treatment of intensive care unit patients at risk for stress gastritis. The Nizatidine Intensive Care Unit Study Group

Scandinavian journal of gastroenterology. Supplement, 1994, Vol.206, p.29-34

1994

Volltextzugriff (PDF)

Nizatidine versus placebo in active benign gastric ulcer disease: an eight-week, multicenter, randomized, double-blind comparison. The Nizatidine Benign Gastric Ulcer Disease Study Group

Clinical pharmacology and therapeutics, 1992-09, Vol.52 (3), p.307

1992

Volltextzugriff (PDF)

Nizatidine versus placebo in active benign gastric ulcer disease: An eight-week, multicenter, randomized, double-blind comparison

Clinical pharmacology and therapeutics, 1992-09, Vol.52 (3), p.307-313

1992

Volltextzugriff (PDF)

Comparison of nizatidine and cimetidine as once-nightly treatment of acute duodenal ulcer. Nizatidine Multicenter Duodenal Ulcer Study Group

The American journal of gastroenterology, 1989-07, Vol.84 (7), p.769

1989

Volltextzugriff (PDF)

Nizatidine versus placebo in gastro-oesophageal reflux disease: a 6-week, multicentre, randomised, double-blind comparison. Nizatidine Gastroesophageal Reflux Disease Study Group

British journal of clinical practice. Supplement, 1994-11, Vol.76, p.11

1994

Volltextzugriff (PDF)

Nizatidine versus placebo in gastro-oesophageal reflux disease: a 12-week, multicentre, randomised, double-blind study

British journal of clinical practice. Supplement, 1994-11, Vol.76, p.3

1994

Volltextzugriff (PDF)

Archipel: Unites 1 a 7

1982

Volltextzugriff (PDF)

Panoramas urbains: Situation de l’histoire des villes

1995

Volltextzugriff (PDF)

1 – 25 von 331

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(261)
Mit Volltextzugriff
(270)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Rabeprazole in treatment of acid peptic diseases : Results of three placebo-controlled dose-response clinical trials in duodenal ulcer, gastric ulcer, and gastroesophageal reflux disease (GERD)

Nizatidine versus placebo in gastroesophageal reflux disease : a 12-week, multicenter, randomized, double-blind study

Continuous Infusions of Nizatidine Are Safe and Effective in the Treatment of Intensive Care Unit Patients at Risk for Stress Gastritis

Safety of Nizatidine in Clinical Trials Conducted in the USA and Europe

Healing and recurrence of active duodenal ulcer with nizatidine

A Test of the Bicolored Fruit Display Hypothesis: Berry Removal with Artificial Fruit Flags

Nizatidine versus placebo in gastroesophageal reflux disease : a six-week, multicenter, randomized, double-blind comparison

Nizatidine as Maintenance Therapy of Duodenal Ulcer Disease in Remission

Treatment of Duodenal Ulceration in the United States

Healing and subsequent recurrence of duodenal ulcer in a clinical trial comparing nizatidine 300-mg and 100-mg evening doses and placebo in the treatment of active duodenal ulcer

A specific LTD4/LTE4-receptor antagonist improves pulmonary function in patients with mild, chronic asthma

Comparison of nizatidine and cimetidine as once-nightly treatment of acute duodenal ulcer

A Brief Review of Preclinical and Clinical Studies with LY171883 and Some Comments on Newer Cysteinyl Leukotriene Receptor Antagonists

Nizatidine prevents peptic ulceration in high-risk patients taking nonsteroidal anti-inflammatory drugs

Rabeprazole in treatment of acid peptic diseases: results of three placebo-controlled dose-response clinical trials in duodenal ulcer, gastric ulcer, and gastroesophageal reflux disease (GERD). The Rabeprazole Study Group

Rabeprazole in treatment of acid peptic diseases (results of three placebo-controlled dose-response clinical trials in duodenal ulcer, gastric ulcer, and gastroesophageal reflux disease (GERD))

Nizatidine versus placebo in gastroesophageal reflux disease. A six-week, multicenter, randomized, double-blind comparison. Nizatidine Gastroesophageal Reflux Disease Study Group

Continuous infusions of nizatidine are safe and effective in the treatment of intensive care unit patients at risk for stress gastritis. The Nizatidine Intensive Care Unit Study Group

Nizatidine versus placebo in active benign gastric ulcer disease: an eight-week, multicenter, randomized, double-blind comparison. The Nizatidine Benign Gastric Ulcer Disease Study Group

Nizatidine versus placebo in active benign gastric ulcer disease: An eight-week, multicenter, randomized, double-blind comparison

Comparison of nizatidine and cimetidine as once-nightly treatment of acute duodenal ulcer. Nizatidine Multicenter Duodenal Ulcer Study Group

Nizatidine versus placebo in gastro-oesophageal reflux disease: a 6-week, multicentre, randomised, double-blind comparison. Nizatidine Gastroesophageal Reflux Disease Study Group

Nizatidine versus placebo in gastro-oesophageal reflux disease: a 12-week, multicentre, randomised, double-blind study

Archipel: Unites 1 a 7

Panoramas urbains: Situation de l’histoire des villes

Suchergebnisse filtern